logo-loader
viewIntegumen

Integumen lands two new Labskin AI deals with cosmetics giants

Two unnamed but ‘top-10 global’ cosmetics companies, have signed deals to use Integumen’s Labskin AI product testing platform

woman's face
Labskin AI is a digital extension to the lab-grown skin which Integumen specialises in

Integumen PLC (LON:SKIN) has landed contracts worth more than £100,000 with two of the of the world’s biggest cosmetics companies.

The industry giants – they are described as “top-10 global cosmetic companies” – will use Integumen’s Labskin AI to test some of their products in a real-world setting.

READ: Open Orphan sells remaining stake in Integumen

Together, the pair of contracts are worth in excess of £100,000, Integumen said, with the potential for continued testing thereafter.

“Integumen is playing a major role in the creation of an innovative AI eco-system that will contribute to the growth of our clients' product range as they develop new skin care products using the LabskinAI virtual platform,” said chief executive Gerry Brandon.

“Right now, LabskinAI serves as a portal for small, medium and large corporations to meet the strict EU regulatory requirements for existing products that are already on the shelf.

“The repeat custom of two global cosmetic companies is testament to the value of the LabskinAI platform for the entire skin care industry.”

In the same announcement, Integumen confirmed that LabskinAI has now completed Beta testing and has fully transitioned from a product sale only company to a virtual and physical test platform for healthcare, personal care, skincare, wound care and pharmaceutical drug discovery eco-system.

Quick facts: Integumen

Price: 1.795 GBX

AIM:SKIN
Market: AIM
Market Cap: £17.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read